DEVS vs MRNA · rev $25.8K vs rev $1.94B
DevvStream Corp. Common Stock (DEVS) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
DevvStream Corp. Common Stock (DEVS) is a pollution & treatment controls company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported DEVS revenue for 2025-07-31 was $25.8K. Net income was -$12.1M. DEVS currently screens at market cap $13.4M.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
DEVS currently screens at market cap $13.4M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the DEVS and MRNA stock pages for the full models.
Not investment advice.